ARCHIVES

Second-Generation CML Drugs Show Promise For Frontline

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Shubik Warns NCA Members They May Be Prober’s Next Target

May 22, 1981

Older Women More Likely To Receive Lower Chemotherapy Doses, Study Finds

August 28, 2009

Cancer Rates Keep Falling, NCI’s Progress Report Says.

December 7, 2001

Cancer Mortality Rate Down 1.3 Percent, ACS Report Finds

July 30, 2010

In Brief: Reducing Doses Cuts Cure Rate Every Time, DeVita Says; Hyperthermia Use In Cancer Being Assessed

April 6, 1984

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

November 29, 2013